DOJ Pfizer’s Subsidiary Biohaven Settles for Nearly $60M Over Speaker Programs:… Thomas Sullivan Jan 27, 2025 0 Pfizer’s subsidiary Biohaven has agreed to a settlement nearing $60 million to resolve allegations of false claims related to…
